Harvia AGM 2026: EUR 0.77 Dividend Approved, Martin Richter Joins Board

Harvia Plc held its 2026 Annual General Meeting in Helsinki on 15 April 2026 at 10:00 a.m. Finnish time. Shareholders approved the board's proposed dividend of EUR 0.77 per share, re-elected six incumbent directors, added Martin Richter to the board, and renewed share buyback and issuance authorizations. Deloitte Oy was re-elected as auditor. (Context on the FY 2025 results that drove the dividend. Full investor coverage: Harvia News hub.)

Dividend

The approved total dividend of EUR 0.77 per share will be paid in two installments. The first installment of EUR 0.39 per share has a record date of 17 April 2026 and a payment date of 24 April 2026. The second installment of EUR 0.38 per share is payable in October 2026, with the record and payment dates left to a board meeting scheduled for 15 October 2026; on the AGM's own wording the record date "would then be" 19 October 2026 and the payment date 26 October 2026. The total represents a 5.5% increase from the EUR 0.73 paid for 2024.

2025 dividend timeline: Total EUR 0.77 per share. First installment EUR 0.39 (record 17 April 2026, payment 24 April 2026). Second installment EUR 0.38 (record 19 October 2026, payment 26 October 2026, both expected and subject to the board's 15 October decision).

Board of Directors

Seven board members were elected. Six incumbents were re-elected: Catharina Stackelberg-Hammarén, Petri Castrén, Anders Holmén, Hille Korhonen, Markus Lengauer, and Olli Liitola. Martin Richter was newly elected to the board. Board compensation was approved at EUR 5,500 monthly for the chair, EUR 4,000 for the deputy chair, and EUR 3,500 for members, with 40% payable in Harvia shares and 60% in cash. Committee chair meeting fees are EUR 1,400, committee member meeting fees EUR 900, and international members receive an additional EUR 900 cash fee per in-person meeting.

Share Authorizations

The board was authorized to repurchase up to 934,711 shares, roughly 5% of shares outstanding. Separately, the board was authorized to issue up to 1,869,423 shares, approximately 10% of outstanding shares. Both authorizations are valid until 30 June 2027 and give the company flexibility to support compensation programs, pursue acquisitions paid partly in stock, or conduct opportunistic buybacks.

Auditor

Deloitte Oy was re-elected as the company's auditor, with Johan Groop serving as Responsible Auditor. Auditor fees are to be paid based on invoice.

The buyback and issuance authorizations keep Harvia's M&A optionality live. On the Q4 2025 earnings call two months earlier, CEO Matias Järnefelt was explicit about the company's posture as a consolidator in the global sauna category.

"Harvia is in a very interesting position. It has the right to play and right to win as a consolidator." — Matias Järnefelt, CEO, Harvia Q4 2025 earnings call, 12 February 2026

Asked on the same call what is on the acquisition wish list, Järnefelt named the category first: "One of the prime candidates is infrared sauna business in the United States." He also named adjacent wellness categories, telling analysts: "We are looking at other significant-sized markets in categories such as cold wellness, digital wellness."

Why It Matters

The AGM outcomes are essentially routine, which is the point. Harvia's governance has stabilized around a well-understood cadence: two-installment dividends, annual share authorizations roughly sized to standard Nordic norms, continuity on the audit side. The addition of Martin Richter, the first new director in several years, brings fresh perspective without disturbing the existing board dynamic. Shareholders approved every board proposal.

The first dividend installment will be paid on 24 April 2026. Harvia's Q1 2026 interim report is scheduled for 7 May 2026. The H1 2026 half-year report is scheduled for 6 August 2026, and the Q3 2026 interim report for 29 October 2026. The 2027 AGM is expected in April 2027.

No surprises at Harvia's 2026 AGM, which in corporate governance is a compliment. The dividend is up 5.5%, the board gained a new voice, and the buyback and issuance authorizations are renewed on standard terms. The company continues to deliver the kind of predictable, well-governed compounding that got it to its 2018 IPO valuation, and has carried it to EUR 198.9 million in revenue since.